US › Healthcare

Xencor Inc (XNCR)

US · Healthcare · Biotechnology

$19.92+2.68%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$4.5M
Revenue YoY
-86.2%
Net profit
$-128.9M
Profit YoY
-166.3%
EPS
$-1.71
EPS estimate
$-0.75
Net margin
-2,854.7%

EPS came in at -1.71 against a street estimate of -0.75 — a miss of 128.0%.

Key statistics

Market cap
$1.45B
Forward P/E
68.0
P/B
2.87
Book value
$6.96
EPS (TTM)
$-2.24
52-week high
$21.76
52-week low
$6.92
50-day MA
$14.36
200-day MA
$13.73
Beta
0.86

Analyst view

Analysts rate Xencor Inc a strong buy (11 buy, 0 hold, 1 sell out of 12) with an average price target of $28.33.

Shareholding

Insiders
1.22%
Institutions
115.15%

Largest institutional holders

FundStake
BlackRock Inc17.58%
PRIMECAP Management Company13.94%
Bvf Inc9.62%
RTW INVESTMENTS, LLC9.14%
RA Capital Management, LLC6.61%
State Street Corp5.87%
Vanguard Portfolio Management, LLC4.72%
Vanguard Capital Management, LLC4.18%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Xencor Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.